Physician profile
Nathaniel Knoll
NPI 1184469777
$2,000.58
in general payments reported to CMS, 2019-2025
11 companies · $1,979 in 2025
The $1,979 reported for 2025 was more than what 92% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $21.80 · 2025: $1,979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,000.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $854.58 | 2025 | Uzedy |
| E.R. Squibb & Sons, L.L.C. | $380.67 | 2025 | Cobenfy |
| Alkermes, INC. | $292.89 | 2024-2025 | Lybalvi, Aristada, Vivitrol |
| Janssen Pharmaceuticals, INC | $176.75 | 2025 | Invega Sustenna |
| Novo Nordisk INC | $106.37 | 2025 | Ozempic, Wegovy |
| Otsuka America Pharmaceutical, INC. | $82.02 | 2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Lilly USA, LLC | $27.02 | 2025 | Mounjaro, Zepbound |
| Hologic Sales and Service, LLC | $22.79 | 2025 | Aptima |
| Neurocrine Biosciences, INC. | $20.79 | 2025 | |
| Phadia US INC. | $19.50 | 2025 | Immunocap |
| Scilex Pharmaceuticals INC. | $17.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Knoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.